In RCC patients, thrombocytopenia is mainly attributed to paraneoplastic syndromes, such as secondary ITP (approximately 20% of all RCC patients) [10], followed by other causes, including IL-6-related thrombocytopenia, secondary DIC, and a few unknown causes. Here, IL6 is linked to renal cell adenocarcinoma.